ProT Gold - OP2 Labs
(Photo : ProT Gold - OP2 Labs)

For patients receiving treatment in hospitals and long-term care facilities, one of the most common risk factors is a hospital-acquired pressure injury (HAPI), also called a pressure ulcer. A HAPI is a localized injury to the skin and underlying tissue, and more severe injuries can lead to longer hospital stays, infection, acute pain, and even death.

According to recent studies published in the journal Nursing Research, "Although healthcare organizations have decreased hospital-acquired pressure injury (HAPI) rates, HAPIs are not eliminated, driving further examination in both nursing and health services research."

One of the most important areas of research is in treatment options for pressure ulcers. Hospitals and long-term care facilities that improve their treatment of pressure ulcers can dramatically reduce patient pain, infection rates, and length of stay in the facility.  

Another critical reason for hospitals to address HAPIs is that after wrongful death, they are the most common hospital lawsuit. Over 2 million patients suffer a pressure ulcer each year, and the cost to treat HAPIs averages $70,000 per patient with additional fees, not including penalties from CMS and lawsuits as a result of wrongful death.  

At OP2 Labs, they have developed a groundbreaking formula of nano-hydrolyzed collagen protein that has shown remarkable results in healthcare facilities across the country. ProT Gold is a revolutionary product that is poised to transform the way providers treat HAPIs. It can be digested in less than 15 minutes - 4 times faster than the leading whey protein formulas - and has been shown to heal wounds 2 times faster than other products in the marketplace.

For hospitals and healthcare providers that want to provide the highest standard of care to their patients, the go-to resource for treating pressure ulcers is ProT Gold.

A 2015 digestibility study completed at the Kennesaw State University Department of Cellular and Molecular Biology concluded that ProT Gold (as well as Frog Fuel, a related product from OP2 Labs) is 100% digestible within 15 minutes, allowing patients to receive faster treatment and recover more quickly:

From the study: "Complete degradation of the FrogFuel product was observed at 15 minutes, whereas other whey products still had more than 70% of proteins detected at that time."

Although rapid digestibility is an important aspect of ProT Gold, its healing power is what truly sets it apart within the healthcare field. In a randomized, prospective, controlled, multicenter trial at 23 long-term-care facilities in 4 states, researchers found that after 8 weeks of treatment, patients in the treatment group had significantly better Pressure Ulcer Scale for Healing (PUSH) scores. In fact, their results "showed approximately twice the rate of pressure ulcer healing in the treatment group compared with the control group."

OP2 Labs has designed a unique formulation that allows for not only rapid absorption but increased healing for patients and long-term care residents. Because of the incredible results they have achieved in clinical studies, they have rapidly become trusted partners for some of the largest healthcare facilities in the world. ProT Gold is regularly used for patients suffering pressure ulcers, delivering fast and effective treatment while reducing pain and wound severity.

It has been so effective that hospitals and providers have used it to treat other wounds as well. ProT Gold has been used to successfully treat burns and frostbite, with patients reporting improvement within the first 24 hours of starting treatment.

OP2 Labs continues to set the standard with their unique formula of nano-hydrolyzed collagen protein, delivering essential treatment options to the patients who need them most. With ProT Gold, they have designed a product that not only relieves pain and generates rapid healing, but a product that saves lives.

To learn more about OP2 Labs and their breakthrough formulation, ProT Gold, visit OP2 Labs.

ⓒ 2024 TECHTIMES.com All rights reserved. Do not reproduce without permission.
* This is a contributed article and this content does not necessarily represent the views of techtimes.com
Join the Discussion